Vi polysaccharide typhoid vaccine (Chengdu Institute of Biological Products)

伤寒Vi多糖疫苗 (成都生物制品研究所)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVi polysaccharide typhoid vaccine (Chengdu Institute of Biological Products)
Drug Alias NameTyphoid vaccine Vi polysaccharide (Chengdu Institute of Biological Products)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsTyphoid Fever
Approved Indications in ChinaTyphoid Fever
Original Approved Country/TerritoryMainland China
Original Approved Date1996/12/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsTyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeJ07AP03
Related LinksN/A